Related references
Note: Only part of the references are listed.Human Papillomavirus Infections Among Couples in New Sexual Relationships
Ann N. Burchell et al.
EPIDEMIOLOGY (2010)
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Chris J. L. M. Meijer et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
V. M. H. Coupe et al.
BRITISH JOURNAL OF CANCER (2008)
Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men
Anna R. Giuliano et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Estimating the impact of school closure on influenza transmission from Sentinel data
Simon Cauchemez et al.
NATURE (2008)
Inapparent infections and cholera dynamics
Aaron A. King et al.
NATURE (2008)
Health and economic implications of HPV vaccination in the United States
Jane J. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands
Maaike A. van der Aa et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting
J. J. Kim et al.
BRITISH JOURNAL OF CANCER (2007)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial
Jorma Paavonen et al.
LANCET (2007)
Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear
Johannes Berkhof et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada
AN Burchell et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: Results from a population-based study in Costa Rica
RP Viscidi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2004)
Pobascam, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women
NWJ Bulkmans et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The causal relation between human papillomavirus and cervical cancer
FX Bosch et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection
JJ Carter et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
